Global Valacyclovir Market Growth 2020-2025
Apr, 2020
|
Report ID: 122021
|
183
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Valacyclovir market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Valacyclovir business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Valacyclovir market by type, application, key manufacturers and key regions and countries.
This study considers the Valacyclovir value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablets
Capsule
Granules
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
PLIVA
Mylan Pharmaceuticals
Sorres Pharma
Sivem Pharmaceuticals
Cobalt Laboratories (Allergan)
Auro Pharma
Remedy Repack
Biomed Pharma
Apotex Corporation
Sichuan Mingxin Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Baili Pharmaceutical
Marcan Pharmaceuticals
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Yichang Dongyangguang Changjiang Pharmaceutical
Beijing Shuanglu Pharmaceutical
Jamp Pharma Corporatio
Ansi Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Yongxin Pharmaceutical Industry
Kunming Yuanrui Pharmaceutical
Hubei Huashitong Qianlong Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Zhuhai Rundu Pharmaceutical
Guangdong Baike Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Beite Pharmaceutical
Jamp Pharma Corporatio
Marcan Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Valacyclovir consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Valacyclovir market by identifying its various subsegments.
Focuses on the key global Valacyclovir manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Valacyclovir with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Valacyclovir submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares, and growth opportunities of Valacyclovir market by type, application, key manufacturers and key regions and countries.
This study considers the Valacyclovir value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablets
Capsule
Granules
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
PLIVA
Mylan Pharmaceuticals
Sorres Pharma
Sivem Pharmaceuticals
Cobalt Laboratories (Allergan)
Auro Pharma
Remedy Repack
Biomed Pharma
Apotex Corporation
Sichuan Mingxin Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Baili Pharmaceutical
Marcan Pharmaceuticals
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Yichang Dongyangguang Changjiang Pharmaceutical
Beijing Shuanglu Pharmaceutical
Jamp Pharma Corporatio
Ansi Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Yongxin Pharmaceutical Industry
Kunming Yuanrui Pharmaceutical
Hubei Huashitong Qianlong Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Zhuhai Rundu Pharmaceutical
Guangdong Baike Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Beite Pharmaceutical
Jamp Pharma Corporatio
Marcan Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Valacyclovir consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Valacyclovir market by identifying its various subsegments.
Focuses on the key global Valacyclovir manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Valacyclovir with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Valacyclovir submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Valacyclovir Consumption 2015-2025
2.1.2 Valacyclovir Consumption CAGR by Region
2.2 Valacyclovir Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Granules
2.3 Valacyclovir Consumption by Type
2.3.1 Global Valacyclovir Consumption Market Share by Type (2015-2020)
2.3.2 Global Valacyclovir Revenue and Market Share by Type (2015-2020)
2.3.3 Global Valacyclovir Sale Price by Type (2015-2020)
2.4 Valacyclovir Segment by Application
2.4.1 Herpes Zoster Virus
2.4.2 Herpes Simplex Virus
2.4.3 EB Virus
2.4.4 Cytomegalovirus
2.5 Valacyclovir Consumption by Application
2.5.1 Global Valacyclovir Consumption Market Share by Type (2015-2020)
2.5.2 Global Valacyclovir Value and Market Share by Type (2015-2020)
2.5.3 Global Valacyclovir Sale Price by Type (2015-2020)
3 Global Valacyclovir by Company
3.1 Global Valacyclovir Sales Market Share by Company
3.1.1 Global Valacyclovir Sales by Company (2018-2020)
3.1.2 Global Valacyclovir Sales Market Share by Company (2018-2020)
3.2 Global Valacyclovir Revenue Market Share by Company
3.2.1 Global Valacyclovir Revenue by Company (2018-2020)
3.2.2 Global Valacyclovir Revenue Market Share by Company (2018-2020)
3.3 Global Valacyclovir Sale Price by Company
3.4 Global Valacyclovir Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Valacyclovir Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Valacyclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Valacyclovir by Regions
4.1 Valacyclovir by Regions
4.2 Americas Valacyclovir Consumption Growth
4.3 APAC Valacyclovir Consumption Growth
4.4 Europe Valacyclovir Consumption Growth
4.5 Middle East & Africa Valacyclovir Consumption Growth
5 Americas
5.1 Americas Valacyclovir Consumption by Countries
5.1.1 Americas Valacyclovir Consumption by Countries (2015-2020)
5.1.2 Americas Valacyclovir Value by Countries (2015-2020)
5.2 Americas Valacyclovir Consumption by Type
5.3 Americas Valacyclovir Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Valacyclovir Consumption by Regions
6.1.1 APAC Valacyclovir Consumption by Regions (2015-2020)
6.1.2 APAC Valacyclovir Value by Regions (2015-2020)
6.2 APAC Valacyclovir Consumption by Type
6.3 APAC Valacyclovir Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Valacyclovir by Countries
7.1.1 Europe Valacyclovir Consumption by Countries (2015-2020)
7.1.2 Europe Valacyclovir Value by Countries (2015-2020)
7.2 Europe Valacyclovir Consumption by Type
7.3 Europe Valacyclovir Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Valacyclovir by Countries
8.1.1 Middle East & Africa Valacyclovir Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Valacyclovir Value by Countries (2015-2020)
8.2 Middle East & Africa Valacyclovir Consumption by Type
8.3 Middle East & Africa Valacyclovir Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Valacyclovir Distributors
10.3 Valacyclovir Customer
11 Global Valacyclovir Market Forecast
11.1 Global Valacyclovir Consumption Forecast (2021-2025)
11.2 Global Valacyclovir Forecast by Regions
11.2.1 Global Valacyclovir Forecast by Regions (2021-2025)
11.2.2 Global Valacyclovir Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Valacyclovir Forecast by Type
11.8 Global Valacyclovir Forecast by Application
12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 Valacyclovir Product Offered
12.1.3 GSK Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
12.2 PLIVA
12.2.1 Company Information
12.2.2 Valacyclovir Product Offered
12.2.3 PLIVA Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 PLIVA Latest Developments
12.3 Mylan Pharmaceuticals
12.3.1 Company Information
12.3.2 Valacyclovir Product Offered
12.3.3 Mylan Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Pharmaceuticals Latest Developments
12.4 Sorres Pharma
12.4.1 Company Information
12.4.2 Valacyclovir Product Offered
12.4.3 Sorres Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sorres Pharma Latest Developments
12.5 Sivem Pharmaceuticals
12.5.1 Company Information
12.5.2 Valacyclovir Product Offered
12.5.3 Sivem Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sivem Pharmaceuticals Latest Developments
12.6 Cobalt Laboratories (Allergan)
12.6.1 Company Information
12.6.2 Valacyclovir Product Offered
12.6.3 Cobalt Laboratories (Allergan) Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Cobalt Laboratories (Allergan) Latest Developments
12.7 Auro Pharma
12.7.1 Company Information
12.7.2 Valacyclovir Product Offered
12.7.3 Auro Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Auro Pharma Latest Developments
12.8 Remedy Repack
12.8.1 Company Information
12.8.2 Valacyclovir Product Offered
12.8.3 Remedy Repack Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Remedy Repack Latest Developments
12.9 Biomed Pharma
12.9.1 Company Information
12.9.2 Valacyclovir Product Offered
12.9.3 Biomed Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Biomed Pharma Latest Developments
12.10 Apotex Corporation
12.10.1 Company Information
12.10.2 Valacyclovir Product Offered
12.10.3 Apotex Corporation Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Apotex Corporation Latest Developments
12.11 Sichuan Mingxin Pharmaceutical
12.11.1 Company Information
12.11.2 Valacyclovir Product Offered
12.11.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sichuan Mingxin Pharmaceutical Latest Developments
12.12 Sichuan Kelun Pharmaceutical
12.12.1 Company Information
12.12.2 Valacyclovir Product Offered
12.12.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sichuan Kelun Pharmaceutical Latest Developments
12.13 Sichuan Baili Pharmaceutical
12.13.1 Company Information
12.13.2 Valacyclovir Product Offered
12.13.3 Sichuan Baili Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sichuan Baili Pharmaceutical Latest Developments
12.14 Marcan Pharmaceuticals
12.14.1 Company Information
12.14.2 Valacyclovir Product Offered
12.14.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Marcan Pharmaceuticals Latest Developments
12.15 Livzon Pharmaceutical Group
12.15.1 Company Information
12.15.2 Valacyclovir Product Offered
12.15.3 Livzon Pharmaceutical Group Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Livzon Pharmaceutical Group Latest Developments
12.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
12.16.1 Company Information
12.16.2 Valacyclovir Product Offered
12.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments
12.17 Yichang Dongyangguang Changjiang Pharmaceutical
12.17.1 Company Information
12.17.2 Valacyclovir Product Offered
12.17.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
12.18 Beijing Shuanglu Pharmaceutical
12.18.1 Company Information
12.18.2 Valacyclovir Product Offered
12.18.3 Beijing Shuanglu Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Beijing Shuanglu Pharmaceutical Latest Developments
12.19 Jamp Pharma Corporatio
12.19.1 Company Information
12.19.2 Valacyclovir Product Offered
12.19.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Jamp Pharma Corporatio Latest Developments
12.20 Ansi Pharmaceutical
12.20.1 Company Information
12.20.2 Valacyclovir Product Offered
12.20.3 Ansi Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Ansi Pharmaceutical Latest Developments
12.21 Hubei Yikang Pharmaceutical Factory
12.21.1 Company Information
12.21.2 Valacyclovir Product Offered
12.21.3 Hubei Yikang Pharmaceutical Factory Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Hubei Yikang Pharmaceutical Factory Latest Developments
12.22 Hubei Keyi Pharmaceutical
12.22.1 Company Information
12.22.2 Valacyclovir Product Offered
12.22.3 Hubei Keyi Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Hubei Keyi Pharmaceutical Latest Developments
12.23 Yongxin Pharmaceutical Industry
12.23.1 Company Information
12.23.2 Valacyclovir Product Offered
12.23.3 Yongxin Pharmaceutical Industry Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Yongxin Pharmaceutical Industry Latest Developments
12.24 Kunming Yuanrui Pharmaceutical
12.24.1 Company Information
12.24.2 Valacyclovir Product Offered
12.24.3 Kunming Yuanrui Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Kunming Yuanrui Pharmaceutical Latest Developments
12.25 Hubei Huashitong Qianlong Pharmaceutical
12.25.1 Company Information
12.25.2 Valacyclovir Product Offered
12.25.3 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Hubei Huashitong Qianlong Pharmaceutical Latest Developments
12.26 Shandong Luoxin Pharmaceutical Group
12.26.1 Company Information
12.26.2 Valacyclovir Product Offered
12.26.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.26.4 Main Business Overview
12.26.5 Shandong Luoxin Pharmaceutical Group Latest Developments
12.27 Zhuhai Rundu Pharmaceutical
12.27.1 Company Information
12.27.2 Valacyclovir Product Offered
12.27.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.27.4 Main Business Overview
12.27.5 Zhuhai Rundu Pharmaceutical Latest Developments
12.28 Guangdong Baike Pharmaceutical
12.28.1 Company Information
12.28.2 Valacyclovir Product Offered
12.28.3 Guangdong Baike Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.28.4 Main Business Overview
12.28.5 Guangdong Baike Pharmaceutical Latest Developments
12.29 Shandong New Era Pharmaceutical
12.29.1 Company Information
12.29.2 Valacyclovir Product Offered
12.29.3 Shandong New Era Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.29.4 Main Business Overview
12.29.5 Shandong New Era Pharmaceutical Latest Developments
12.30 Chengdu Beite Pharmaceutical
12.30.1 Company Information
12.30.2 Valacyclovir Product Offered
12.30.3 Chengdu Beite Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.30.4 Main Business Overview
12.30.5 Chengdu Beite Pharmaceutical Latest Developments
12.31 Jamp Pharma Corporatio
12.32 Marcan Pharmaceuticals
13 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Valacyclovir Consumption 2015-2025
2.1.2 Valacyclovir Consumption CAGR by Region
2.2 Valacyclovir Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Granules
2.3 Valacyclovir Consumption by Type
2.3.1 Global Valacyclovir Consumption Market Share by Type (2015-2020)
2.3.2 Global Valacyclovir Revenue and Market Share by Type (2015-2020)
2.3.3 Global Valacyclovir Sale Price by Type (2015-2020)
2.4 Valacyclovir Segment by Application
2.4.1 Herpes Zoster Virus
2.4.2 Herpes Simplex Virus
2.4.3 EB Virus
2.4.4 Cytomegalovirus
2.5 Valacyclovir Consumption by Application
2.5.1 Global Valacyclovir Consumption Market Share by Type (2015-2020)
2.5.2 Global Valacyclovir Value and Market Share by Type (2015-2020)
2.5.3 Global Valacyclovir Sale Price by Type (2015-2020)
3 Global Valacyclovir by Company
3.1 Global Valacyclovir Sales Market Share by Company
3.1.1 Global Valacyclovir Sales by Company (2018-2020)
3.1.2 Global Valacyclovir Sales Market Share by Company (2018-2020)
3.2 Global Valacyclovir Revenue Market Share by Company
3.2.1 Global Valacyclovir Revenue by Company (2018-2020)
3.2.2 Global Valacyclovir Revenue Market Share by Company (2018-2020)
3.3 Global Valacyclovir Sale Price by Company
3.4 Global Valacyclovir Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Valacyclovir Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Valacyclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Valacyclovir by Regions
4.1 Valacyclovir by Regions
4.2 Americas Valacyclovir Consumption Growth
4.3 APAC Valacyclovir Consumption Growth
4.4 Europe Valacyclovir Consumption Growth
4.5 Middle East & Africa Valacyclovir Consumption Growth
5 Americas
5.1 Americas Valacyclovir Consumption by Countries
5.1.1 Americas Valacyclovir Consumption by Countries (2015-2020)
5.1.2 Americas Valacyclovir Value by Countries (2015-2020)
5.2 Americas Valacyclovir Consumption by Type
5.3 Americas Valacyclovir Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Valacyclovir Consumption by Regions
6.1.1 APAC Valacyclovir Consumption by Regions (2015-2020)
6.1.2 APAC Valacyclovir Value by Regions (2015-2020)
6.2 APAC Valacyclovir Consumption by Type
6.3 APAC Valacyclovir Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Valacyclovir by Countries
7.1.1 Europe Valacyclovir Consumption by Countries (2015-2020)
7.1.2 Europe Valacyclovir Value by Countries (2015-2020)
7.2 Europe Valacyclovir Consumption by Type
7.3 Europe Valacyclovir Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Valacyclovir by Countries
8.1.1 Middle East & Africa Valacyclovir Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Valacyclovir Value by Countries (2015-2020)
8.2 Middle East & Africa Valacyclovir Consumption by Type
8.3 Middle East & Africa Valacyclovir Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Valacyclovir Distributors
10.3 Valacyclovir Customer
11 Global Valacyclovir Market Forecast
11.1 Global Valacyclovir Consumption Forecast (2021-2025)
11.2 Global Valacyclovir Forecast by Regions
11.2.1 Global Valacyclovir Forecast by Regions (2021-2025)
11.2.2 Global Valacyclovir Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Valacyclovir Forecast by Type
11.8 Global Valacyclovir Forecast by Application
12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 Valacyclovir Product Offered
12.1.3 GSK Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
12.2 PLIVA
12.2.1 Company Information
12.2.2 Valacyclovir Product Offered
12.2.3 PLIVA Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 PLIVA Latest Developments
12.3 Mylan Pharmaceuticals
12.3.1 Company Information
12.3.2 Valacyclovir Product Offered
12.3.3 Mylan Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Pharmaceuticals Latest Developments
12.4 Sorres Pharma
12.4.1 Company Information
12.4.2 Valacyclovir Product Offered
12.4.3 Sorres Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sorres Pharma Latest Developments
12.5 Sivem Pharmaceuticals
12.5.1 Company Information
12.5.2 Valacyclovir Product Offered
12.5.3 Sivem Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sivem Pharmaceuticals Latest Developments
12.6 Cobalt Laboratories (Allergan)
12.6.1 Company Information
12.6.2 Valacyclovir Product Offered
12.6.3 Cobalt Laboratories (Allergan) Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Cobalt Laboratories (Allergan) Latest Developments
12.7 Auro Pharma
12.7.1 Company Information
12.7.2 Valacyclovir Product Offered
12.7.3 Auro Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Auro Pharma Latest Developments
12.8 Remedy Repack
12.8.1 Company Information
12.8.2 Valacyclovir Product Offered
12.8.3 Remedy Repack Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Remedy Repack Latest Developments
12.9 Biomed Pharma
12.9.1 Company Information
12.9.2 Valacyclovir Product Offered
12.9.3 Biomed Pharma Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Biomed Pharma Latest Developments
12.10 Apotex Corporation
12.10.1 Company Information
12.10.2 Valacyclovir Product Offered
12.10.3 Apotex Corporation Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Apotex Corporation Latest Developments
12.11 Sichuan Mingxin Pharmaceutical
12.11.1 Company Information
12.11.2 Valacyclovir Product Offered
12.11.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sichuan Mingxin Pharmaceutical Latest Developments
12.12 Sichuan Kelun Pharmaceutical
12.12.1 Company Information
12.12.2 Valacyclovir Product Offered
12.12.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sichuan Kelun Pharmaceutical Latest Developments
12.13 Sichuan Baili Pharmaceutical
12.13.1 Company Information
12.13.2 Valacyclovir Product Offered
12.13.3 Sichuan Baili Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sichuan Baili Pharmaceutical Latest Developments
12.14 Marcan Pharmaceuticals
12.14.1 Company Information
12.14.2 Valacyclovir Product Offered
12.14.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Marcan Pharmaceuticals Latest Developments
12.15 Livzon Pharmaceutical Group
12.15.1 Company Information
12.15.2 Valacyclovir Product Offered
12.15.3 Livzon Pharmaceutical Group Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Livzon Pharmaceutical Group Latest Developments
12.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
12.16.1 Company Information
12.16.2 Valacyclovir Product Offered
12.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments
12.17 Yichang Dongyangguang Changjiang Pharmaceutical
12.17.1 Company Information
12.17.2 Valacyclovir Product Offered
12.17.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
12.18 Beijing Shuanglu Pharmaceutical
12.18.1 Company Information
12.18.2 Valacyclovir Product Offered
12.18.3 Beijing Shuanglu Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Beijing Shuanglu Pharmaceutical Latest Developments
12.19 Jamp Pharma Corporatio
12.19.1 Company Information
12.19.2 Valacyclovir Product Offered
12.19.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Jamp Pharma Corporatio Latest Developments
12.20 Ansi Pharmaceutical
12.20.1 Company Information
12.20.2 Valacyclovir Product Offered
12.20.3 Ansi Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Ansi Pharmaceutical Latest Developments
12.21 Hubei Yikang Pharmaceutical Factory
12.21.1 Company Information
12.21.2 Valacyclovir Product Offered
12.21.3 Hubei Yikang Pharmaceutical Factory Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Hubei Yikang Pharmaceutical Factory Latest Developments
12.22 Hubei Keyi Pharmaceutical
12.22.1 Company Information
12.22.2 Valacyclovir Product Offered
12.22.3 Hubei Keyi Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Hubei Keyi Pharmaceutical Latest Developments
12.23 Yongxin Pharmaceutical Industry
12.23.1 Company Information
12.23.2 Valacyclovir Product Offered
12.23.3 Yongxin Pharmaceutical Industry Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Yongxin Pharmaceutical Industry Latest Developments
12.24 Kunming Yuanrui Pharmaceutical
12.24.1 Company Information
12.24.2 Valacyclovir Product Offered
12.24.3 Kunming Yuanrui Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Kunming Yuanrui Pharmaceutical Latest Developments
12.25 Hubei Huashitong Qianlong Pharmaceutical
12.25.1 Company Information
12.25.2 Valacyclovir Product Offered
12.25.3 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Hubei Huashitong Qianlong Pharmaceutical Latest Developments
12.26 Shandong Luoxin Pharmaceutical Group
12.26.1 Company Information
12.26.2 Valacyclovir Product Offered
12.26.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.26.4 Main Business Overview
12.26.5 Shandong Luoxin Pharmaceutical Group Latest Developments
12.27 Zhuhai Rundu Pharmaceutical
12.27.1 Company Information
12.27.2 Valacyclovir Product Offered
12.27.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.27.4 Main Business Overview
12.27.5 Zhuhai Rundu Pharmaceutical Latest Developments
12.28 Guangdong Baike Pharmaceutical
12.28.1 Company Information
12.28.2 Valacyclovir Product Offered
12.28.3 Guangdong Baike Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.28.4 Main Business Overview
12.28.5 Guangdong Baike Pharmaceutical Latest Developments
12.29 Shandong New Era Pharmaceutical
12.29.1 Company Information
12.29.2 Valacyclovir Product Offered
12.29.3 Shandong New Era Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.29.4 Main Business Overview
12.29.5 Shandong New Era Pharmaceutical Latest Developments
12.30 Chengdu Beite Pharmaceutical
12.30.1 Company Information
12.30.2 Valacyclovir Product Offered
12.30.3 Chengdu Beite Pharmaceutical Valacyclovir Sales, Revenue, Price and Gross Margin (2018-2020)
12.30.4 Main Business Overview
12.30.5 Chengdu Beite Pharmaceutical Latest Developments
12.31 Jamp Pharma Corporatio
12.32 Marcan Pharmaceuticals
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Valacyclovir Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablets
Table 5. Major Players of Capsule
Table 6. Major Players of Granules
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Valacyclovir Consumption Market Share by Type (2015-2020)
Table 9. Global Valacyclovir Revenue by Type (2015-2020) ($ million)
Table 10. Global Valacyclovir Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Valacyclovir Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Valacyclovir Consumption Market Share by Application (2015-2020)
Table 14. Global Valacyclovir Value by Application (2015-2020)
Table 15. Global Valacyclovir Value Market Share by Application (2015-2020)
Table 16. Global Valacyclovir Sale Price by Application (2015-2020)
Table 17. Global Valacyclovir Sales by Company (2017-2019) (KG)
Table 18. Global Valacyclovir Sales Market Share by Company (2017-2019)
Table 19. Global Valacyclovir Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Valacyclovir Revenue Market Share by Company (2017-2019)
Table 21. Global Valacyclovir Sale Price by Company (2017-2019)
Table 22. Global Valacyclovir Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Valacyclovir Products Offered
Table 24. Valacyclovir Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Valacyclovir Consumption by Regions 2015-2020 (KG)
Table 26. Global Valacyclovir Consumption Market Share by Regions 2015-2020
Table 27. Global Valacyclovir Value by Regions 2015-2020 ($ Millions)
Table 28. Global Valacyclovir Value Market Share by Regions 2015-2020
Table 29. Americas Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 30. Americas Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 31. Americas Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Valacyclovir Value Market Share by Countries (2015-2020)
Table 33. Americas Valacyclovir Consumption by Type (2015-2020) (KG)
Table 34. Americas Valacyclovir Consumption Market Share by Type (2015-2020)
Table 35. Americas Valacyclovir Consumption by Application (2015-2020) (KG)
Table 36. Americas Valacyclovir Consumption Market Share by Application (2015-2020)
Table 37. APAC Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 38. APAC Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 39. APAC Valacyclovir Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Valacyclovir Value Market Share by Regions (2015-2020)
Table 41. APAC Valacyclovir Consumption by Type (2015-2020) (KG)
Table 42. APAC Valacyclovir Consumption Market Share by Type (2015-2020)
Table 43. APAC Valacyclovir Consumption by Application (2015-2020) (KG)
Table 44. APAC Valacyclovir Consumption Market Share by Application (2015-2020)
Table 45. Europe Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 46. Europe Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 47. Europe Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Valacyclovir Value Market Share by Countries (2015-2020)
Table 49. Europe Valacyclovir Consumption by Type (2015-2020) (KG)
Table 50. Europe Valacyclovir Consumption Market Share by Type (2015-2020)
Table 51. Europe Valacyclovir Consumption by Application (2015-2020) (KG)
Table 52. Europe Valacyclovir Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 54. Middle East & Africa Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Valacyclovir Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Valacyclovir Consumption by Type (2015-2020) (KG)
Table 58. Middle East & Africa Valacyclovir Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Valacyclovir Consumption by Application (2015-2020) (KG)
Table 60. Middle East & Africa Valacyclovir Consumption Market Share by Application (2015-2020)
Table 61. Valacyclovir Distributors List
Table 62. Valacyclovir Customer List
Table 63. Global Valacyclovir Consumption Forecast by Countries (2021-2025) (KG)
Table 64. Global Valacyclovir Consumption Market Forecast by Regions
Table 65. Global Valacyclovir Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Valacyclovir Value Market Share Forecast by Regions
Table 67. Global Valacyclovir Consumption Forecast by Type (2021-2025) (KG)
Table 68. Global Valacyclovir Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Valacyclovir Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Valacyclovir Value Market Share Forecast by Type (2021-2025)
Table 71. Global Valacyclovir Consumption Forecast by Application (2021-2025) (KG)
Table 72. Global Valacyclovir Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Valacyclovir Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Valacyclovir Value Market Share Forecast by Application (2021-2025)
Table 75. GSK Product Offered
Table 76. GSK Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. GSK Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 80. PLIVA Product Offered
Table 81. PLIVA Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 82. PLIVA Main Business
Table 83. PLIVA Latest Developments
Table 84. PLIVA Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Pharmaceuticals Product Offered
Table 86. Mylan Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 87. Mylan Pharmaceuticals Main Business
Table 88. Mylan Pharmaceuticals Latest Developments
Table 89. Mylan Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 90. Sorres Pharma Product Offered
Table 91. Sorres Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 92. Sorres Pharma Main Business
Table 93. Sorres Pharma Latest Developments
Table 94. Sorres Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 95. Sivem Pharmaceuticals Product Offered
Table 96. Sivem Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 97. Sivem Pharmaceuticals Main Business
Table 98. Sivem Pharmaceuticals Latest Developments
Table 99. Sivem Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 100. Cobalt Laboratories (Allergan) Product Offered
Table 101. Cobalt Laboratories (Allergan) Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 102. Cobalt Laboratories (Allergan) Main Business
Table 103. Cobalt Laboratories (Allergan) Latest Developments
Table 104. Cobalt Laboratories (Allergan) Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 105. Auro Pharma Product Offered
Table 106. Auro Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 107. Auro Pharma Main Business
Table 108. Auro Pharma Latest Developments
Table 109. Auro Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 110. Remedy Repack Product Offered
Table 111. Remedy Repack Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 112. Remedy Repack Main Business
Table 113. Remedy Repack Latest Developments
Table 114. Remedy Repack Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 115. Biomed Pharma Product Offered
Table 116. Biomed Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 117. Biomed Pharma Main Business
Table 118. Biomed Pharma Latest Developments
Table 119. Biomed Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 120. Apotex Corporation Product Offered
Table 121. Apotex Corporation Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 122. Apotex Corporation Main Business
Table 123. Apotex Corporation Latest Developments
Table 124. Apotex Corporation Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 125. Sichuan Mingxin Pharmaceutical Product Offered
Table 126. Sichuan Mingxin Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 127. Sichuan Mingxin Pharmaceutical Main Business
Table 128. Sichuan Mingxin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Sichuan Mingxin Pharmaceutical Latest Developments
Table 130. Sichuan Kelun Pharmaceutical Product Offered
Table 131. Sichuan Kelun Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 132. Sichuan Kelun Pharmaceutical Main Business
Table 133. Sichuan Kelun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Sichuan Kelun Pharmaceutical Latest Developments
Table 135. Sichuan Baili Pharmaceutical Product Offered
Table 136. Sichuan Baili Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 137. Sichuan Baili Pharmaceutical Main Business
Table 138. Sichuan Baili Pharmaceutical Latest Developments
Table 139. Sichuan Baili Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Marcan Pharmaceuticals Product Offered
Table 141. Marcan Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 142. Marcan Pharmaceuticals Main Business
Table 143. Marcan Pharmaceuticals Latest Developments
Table 144. Marcan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Livzon Pharmaceutical Group Product Offered
Table 146. Livzon Pharmaceutical Group Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 147. Livzon Pharmaceutical Group Main Business
Table 148. Livzon Pharmaceutical Group Latest Developments
Table 149. Livzon Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Product Offered
Table 151. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 152. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Main Business
Table 153. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments
Table 154. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Yichang Dongyangguang Changjiang Pharmaceutical Product Offered
Table 156. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 157. Yichang Dongyangguang Changjiang Pharmaceutical Main Business
Table 158. Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
Table 159. Yichang Dongyangguang Changjiang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. Beijing Shuanglu Pharmaceutical Product Offered
Table 161. Beijing Shuanglu Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 162. Beijing Shuanglu Pharmaceutical Main Business
Table 163. Beijing Shuanglu Pharmaceutical Latest Developments
Table 164. Beijing Shuanglu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 165. Jamp Pharma Corporatio Product Offered
Table 166. Jamp Pharma Corporatio Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 167. Jamp Pharma Corporatio Main Business
Table 168. Jamp Pharma Corporatio Latest Developments
Table 169. Jamp Pharma Corporatio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 170. Ansi Pharmaceutical Product Offered
Table 171. Ansi Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 172. Ansi Pharmaceutical Main Business
Table 173. Ansi Pharmaceutical Latest Developments
Table 174. Ansi Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 175. Hubei Yikang Pharmaceutical Factory Product Offered
Table 176. Hubei Yikang Pharmaceutical Factory Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 177. Hubei Yikang Pharmaceutical Factory Main Business
Table 178. Hubei Yikang Pharmaceutical Factory Latest Developments
Table 179. Hubei Yikang Pharmaceutical Factory Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 180. Hubei Keyi Pharmaceutical Product Offered
Table 181. Hubei Keyi Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 182. Hubei Keyi Pharmaceutical Main Business
Table 183. Hubei Keyi Pharmaceutical Latest Developments
Table 184. Hubei Keyi Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 185. Yongxin Pharmaceutical Industry Product Offered
Table 186. Yongxin Pharmaceutical Industry Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 187. Yongxin Pharmaceutical Industry Main Business
Table 188. Yongxin Pharmaceutical Industry Latest Developments
Table 189. Yongxin Pharmaceutical Industry Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 190. Kunming Yuanrui Pharmaceutical Product Offered
Table 191. Kunming Yuanrui Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 192. Kunming Yuanrui Pharmaceutical Main Business
Table 193. Kunming Yuanrui Pharmaceutical Latest Developments
Table 194. Kunming Yuanrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 195. Hubei Huashitong Qianlong Pharmaceutical Product Offered
Table 196. Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 197. Hubei Huashitong Qianlong Pharmaceutical Main Business
Table 198. Hubei Huashitong Qianlong Pharmaceutical Latest Developments
Table 199. Hubei Huashitong Qianlong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 200. Shandong Luoxin Pharmaceutical Group Product Offered
Table 201. Shandong Luoxin Pharmaceutical Group Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 202. Shandong Luoxin Pharmaceutical Group Main Business
Table 203. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 204. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 205. Zhuhai Rundu Pharmaceutical Product Offered
Table 206. Zhuhai Rundu Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 207. Zhuhai Rundu Pharmaceutical Main Business
Table 208. Zhuhai Rundu Pharmaceutical Latest Developments
Table 209. Zhuhai Rundu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 210. Guangdong Baike Pharmaceutical Product Offered
Table 211. Guangdong Baike Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 212. Guangdong Baike Pharmaceutical Main Business
Table 213. Guangdong Baike Pharmaceutical Latest Developments
Table 214. Guangdong Baike Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 215. Shandong New Era Pharmaceutical Product Offered
Table 216. Shandong New Era Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 217. Shandong New Era Pharmaceutical Main Business
Table 218. Shandong New Era Pharmaceutical Latest Developments
Table 219. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 220. Chengdu Beite Pharmaceutical Product Offered
Table 221. Chengdu Beite Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 222. Chengdu Beite Pharmaceutical Main Business
Table 223. Chengdu Beite Pharmaceutical Latest Developments
Table 224. Chengdu Beite Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 225. Jamp Pharma Corporatio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 226. Marcan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Valacyclovir
Figure 2. Valacyclovir Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Valacyclovir Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Valacyclovir Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablets
Figure 7. Product Picture of Capsule
Figure 8. Product Picture of Granules
Figure 9. Global Valacyclovir Consumption Market Share by Type (2015-2020)
Figure 10. Global Valacyclovir Value Market Share by Type (2015-2020)
Figure 11. Valacyclovir Consumed in Herpes Zoster Virus
Figure 12. Global Valacyclovir Market: Herpes Zoster Virus (2015-2020) (KG)
Figure 13. Global Valacyclovir Market: Herpes Zoster Virus (2015-2020) ($ Millions)
Figure 14. Valacyclovir Consumed in Herpes Simplex Virus
Figure 15. Global Valacyclovir Market: Herpes Simplex Virus (2015-2020) (KG)
Figure 16. Global Valacyclovir Market: Herpes Simplex Virus (2015-2020) ($ Millions)
Figure 17. Valacyclovir Consumed in EB Virus
Figure 18. Global Valacyclovir Market: EB Virus (2015-2020) (KG)
Figure 19. Global Valacyclovir Market: EB Virus (2015-2020) ($ Millions)
Figure 20. Valacyclovir Consumed in Cytomegalovirus
Figure 21. Global Valacyclovir Market: Cytomegalovirus (2015-2020) (KG)
Figure 22. Global Valacyclovir Market: Cytomegalovirus (2015-2020) ($ Millions)
Figure 23. Global Valacyclovir Consumption Market Share by Application (2015-2020)
Figure 24. Global Valacyclovir Value Market Share by Application (2015-2020)
Figure 25. Global Valacyclovir Sales Market Share by Company in 2017
Figure 26. Global Valacyclovir Sales Market Share by Company in 2019
Figure 27. Global Valacyclovir Revenue Market Share by Company in 2017
Figure 28. Global Valacyclovir Revenue Market Share by Company in 2019
Figure 29. Global Valacyclovir Sale Price by Company in 2019
Figure 30. Global Valacyclovir Consumption Market Share by Regions 2015-2020
Figure 31. Global Valacyclovir Value Market Share by Regions 2015-2020
Figure 32. Americas Valacyclovir Consumption 2015-2020 (KG)
Figure 33. Americas Valacyclovir Value 2015-2020 ($ Millions)
Figure 34. APAC Valacyclovir Consumption 2015-2020 (KG)
Figure 35. APAC Valacyclovir Value 2015-2020 ($ Millions)
Figure 36. Europe Valacyclovir Consumption 2015-2020 (KG)
Figure 37. Europe Valacyclovir Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Valacyclovir Consumption 2015-2020 (KG)
Figure 39. Middle East & Africa Valacyclovir Value 2015-2020 ($ Millions)
Figure 40. Americas Valacyclovir Consumption Market Share by Countries in 2019
Figure 41. Americas Valacyclovir Value Market Share by Countries in 2019
Figure 42. Americas Valacyclovir Consumption Market Share by Type in 2019
Figure 43. Americas Valacyclovir Consumption Market Share by Application in 2019
Figure 44. United States Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 45. United States Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 47. Canada Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 49. Mexico Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Valacyclovir Consumption Market Share by Countries in 2019
Figure 51. APAC Valacyclovir Value Market Share by Regions in 2019
Figure 52. APAC Valacyclovir Consumption Market Share by Type in 2019
Figure 53. APAC Valacyclovir Consumption Market Share by Application in 2019
Figure 54. China Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 55. China Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 57. Japan Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 59. Korea Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 61. Southeast Asia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 62. India Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 63. India Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 65. Australia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Valacyclovir Consumption Market Share by Countries in 2019
Figure 67. Europe Valacyclovir Value Market Share by Countries in 2019
Figure 68. Europe Valacyclovir Consumption Market Share by Type in 2019
Figure 69. Europe Valacyclovir Consumption Market Share by Application in 2019
Figure 70. Germany Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 71. Germany Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 72. France Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 73. France Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 74. UK Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 75. UK Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 77. Italy Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 79. Russia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Valacyclovir Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Valacyclovir Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Valacyclovir Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Valacyclovir Consumption Market Share by Application in 2019
Figure 84. Egypt Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 85. Egypt Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 87. South Africa Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 89. Israel Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 91. Turkey Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 93. GCC Countries Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 94. Global Valacyclovir Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 95. Global Valacyclovir Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Valacyclovir Consumption 2021-2025 (KG)
Figure 97. Americas Valacyclovir Value 2021-2025 ($ Millions)
Figure 98. APAC Valacyclovir Consumption 2021-2025 (KG)
Figure 99. APAC Valacyclovir Value 2021-2025 ($ Millions)
Figure 100. Europe Valacyclovir Consumption 2021-2025 (KG)
Figure 101. Europe Valacyclovir Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Valacyclovir Consumption 2021-2025 (KG)
Figure 103. Middle East & Africa Valacyclovir Value 2021-2025 ($ Millions)
Figure 104. United States Valacyclovir Consumption 2021-2025 (KG)
Figure 105. United States Valacyclovir Value 2021-2025 ($ Millions)
Figure 106. Canada Valacyclovir Consumption 2021-2025 (KG)
Figure 107. Canada Valacyclovir Value 2021-2025 ($ Millions)
Figure 108. Mexico Valacyclovir Consumption 2021-2025 (KG)
Figure 109. Mexico Valacyclovir Value 2021-2025 ($ Millions)
Figure 110. Brazil Valacyclovir Consumption 2021-2025 (KG)
Figure 111. Brazil Valacyclovir Value 2021-2025 ($ Millions)
Figure 112. China Valacyclovir Consumption 2021-2025 (KG)
Figure 113. China Valacyclovir Value 2021-2025 ($ Millions)
Figure 114. Japan Valacyclovir Consumption 2021-2025 (KG)
Figure 115. Japan Valacyclovir Value 2021-2025 ($ Millions)
Figure 116. Korea Valacyclovir Consumption 2021-2025 (KG)
Figure 117. Korea Valacyclovir Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Valacyclovir Consumption 2021-2025 (KG)
Figure 119. Southeast Asia Valacyclovir Value 2021-2025 ($ Millions)
Figure 120. India Valacyclovir Consumption 2021-2025 (KG)
Figure 121. India Valacyclovir Value 2021-2025 ($ Millions)
Figure 122. Australia Valacyclovir Consumption 2021-2025 (KG)
Figure 123. Australia Valacyclovir Value 2021-2025 ($ Millions)
Figure 124. Germany Valacyclovir Consumption 2021-2025 (KG)
Figure 125. Germany Valacyclovir Value 2021-2025 ($ Millions)
Figure 126. France Valacyclovir Consumption 2021-2025 (KG)
Figure 127. France Valacyclovir Value 2021-2025 ($ Millions)
Figure 128. UK Valacyclovir Consumption 2021-2025 (KG)
Figure 129. UK Valacyclovir Value 2021-2025 ($ Millions)
Figure 130. Italy Valacyclovir Consumption 2021-2025 (KG)
Figure 131. Italy Valacyclovir Value 2021-2025 ($ Millions)
Figure 132. Russia Valacyclovir Consumption 2021-2025 (KG)
Figure 133. Russia Valacyclovir Value 2021-2025 ($ Millions)
Figure 134. Spain Valacyclovir Consumption 2021-2025 (KG)
Figure 135. Spain Valacyclovir Value 2021-2025 ($ Millions)
Figure 136. Egypt Valacyclovir Consumption 2021-2025 (KG)
Figure 137. Egypt Valacyclovir Value 2021-2025 ($ Millions)
Figure 138. South Africa Valacyclovir Consumption 2021-2025 (KG)
Figure 139. South Africa Valacyclovir Value 2021-2025 ($ Millions)
Figure 140. Israel Valacyclovir Consumption 2021-2025 (KG)
Figure 141. Israel Valacyclovir Value 2021-2025 ($ Millions)
Figure 142. Turkey Valacyclovir Consumption 2021-2025 (KG)
Figure 143. Turkey Valacyclovir Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Valacyclovir Consumption 2021-2025 (KG)
Figure 145. GCC Countries Valacyclovir Value 2021-2025 ($ Millions)
Figure 146. GSK Valacyclovir Market Share (2018-2020)
Figure 147. PLIVA Valacyclovir Market Share (2018-2020)
Figure 148. Mylan Pharmaceuticals Valacyclovir Market Share (2018-2020)
Figure 149. Sorres Pharma Valacyclovir Market Share (2018-2020)
Figure 150. Sivem Pharmaceuticals Valacyclovir Market Share (2018-2020)
Figure 151. Cobalt Laboratories (Allergan) Valacyclovir Market Share (2018-2020)
Figure 152. Auro Pharma Valacyclovir Market Share (2018-2020)
Figure 153. Remedy Repack Valacyclovir Market Share (2018-2020)
Figure 154. Biomed Pharma Valacyclovir Market Share (2018-2020)
Figure 155. Apotex Corporation Valacyclovir Market Share (2018-2020)
Figure 156. Sichuan Mingxin Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 157. Sichuan Kelun Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 158. Sichuan Baili Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 159. Marc
Table 1. Research Methodology
Table 2. Data Source
Table 3. Valacyclovir Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablets
Table 5. Major Players of Capsule
Table 6. Major Players of Granules
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Valacyclovir Consumption Market Share by Type (2015-2020)
Table 9. Global Valacyclovir Revenue by Type (2015-2020) ($ million)
Table 10. Global Valacyclovir Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Valacyclovir Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Valacyclovir Consumption Market Share by Application (2015-2020)
Table 14. Global Valacyclovir Value by Application (2015-2020)
Table 15. Global Valacyclovir Value Market Share by Application (2015-2020)
Table 16. Global Valacyclovir Sale Price by Application (2015-2020)
Table 17. Global Valacyclovir Sales by Company (2017-2019) (KG)
Table 18. Global Valacyclovir Sales Market Share by Company (2017-2019)
Table 19. Global Valacyclovir Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Valacyclovir Revenue Market Share by Company (2017-2019)
Table 21. Global Valacyclovir Sale Price by Company (2017-2019)
Table 22. Global Valacyclovir Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Valacyclovir Products Offered
Table 24. Valacyclovir Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Valacyclovir Consumption by Regions 2015-2020 (KG)
Table 26. Global Valacyclovir Consumption Market Share by Regions 2015-2020
Table 27. Global Valacyclovir Value by Regions 2015-2020 ($ Millions)
Table 28. Global Valacyclovir Value Market Share by Regions 2015-2020
Table 29. Americas Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 30. Americas Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 31. Americas Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Valacyclovir Value Market Share by Countries (2015-2020)
Table 33. Americas Valacyclovir Consumption by Type (2015-2020) (KG)
Table 34. Americas Valacyclovir Consumption Market Share by Type (2015-2020)
Table 35. Americas Valacyclovir Consumption by Application (2015-2020) (KG)
Table 36. Americas Valacyclovir Consumption Market Share by Application (2015-2020)
Table 37. APAC Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 38. APAC Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 39. APAC Valacyclovir Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Valacyclovir Value Market Share by Regions (2015-2020)
Table 41. APAC Valacyclovir Consumption by Type (2015-2020) (KG)
Table 42. APAC Valacyclovir Consumption Market Share by Type (2015-2020)
Table 43. APAC Valacyclovir Consumption by Application (2015-2020) (KG)
Table 44. APAC Valacyclovir Consumption Market Share by Application (2015-2020)
Table 45. Europe Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 46. Europe Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 47. Europe Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Valacyclovir Value Market Share by Countries (2015-2020)
Table 49. Europe Valacyclovir Consumption by Type (2015-2020) (KG)
Table 50. Europe Valacyclovir Consumption Market Share by Type (2015-2020)
Table 51. Europe Valacyclovir Consumption by Application (2015-2020) (KG)
Table 52. Europe Valacyclovir Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Valacyclovir Consumption by Countries (2015-2020) (KG)
Table 54. Middle East & Africa Valacyclovir Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Valacyclovir Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Valacyclovir Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Valacyclovir Consumption by Type (2015-2020) (KG)
Table 58. Middle East & Africa Valacyclovir Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Valacyclovir Consumption by Application (2015-2020) (KG)
Table 60. Middle East & Africa Valacyclovir Consumption Market Share by Application (2015-2020)
Table 61. Valacyclovir Distributors List
Table 62. Valacyclovir Customer List
Table 63. Global Valacyclovir Consumption Forecast by Countries (2021-2025) (KG)
Table 64. Global Valacyclovir Consumption Market Forecast by Regions
Table 65. Global Valacyclovir Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Valacyclovir Value Market Share Forecast by Regions
Table 67. Global Valacyclovir Consumption Forecast by Type (2021-2025) (KG)
Table 68. Global Valacyclovir Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Valacyclovir Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Valacyclovir Value Market Share Forecast by Type (2021-2025)
Table 71. Global Valacyclovir Consumption Forecast by Application (2021-2025) (KG)
Table 72. Global Valacyclovir Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Valacyclovir Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Valacyclovir Value Market Share Forecast by Application (2021-2025)
Table 75. GSK Product Offered
Table 76. GSK Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. GSK Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 80. PLIVA Product Offered
Table 81. PLIVA Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 82. PLIVA Main Business
Table 83. PLIVA Latest Developments
Table 84. PLIVA Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Pharmaceuticals Product Offered
Table 86. Mylan Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 87. Mylan Pharmaceuticals Main Business
Table 88. Mylan Pharmaceuticals Latest Developments
Table 89. Mylan Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 90. Sorres Pharma Product Offered
Table 91. Sorres Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 92. Sorres Pharma Main Business
Table 93. Sorres Pharma Latest Developments
Table 94. Sorres Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 95. Sivem Pharmaceuticals Product Offered
Table 96. Sivem Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 97. Sivem Pharmaceuticals Main Business
Table 98. Sivem Pharmaceuticals Latest Developments
Table 99. Sivem Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 100. Cobalt Laboratories (Allergan) Product Offered
Table 101. Cobalt Laboratories (Allergan) Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 102. Cobalt Laboratories (Allergan) Main Business
Table 103. Cobalt Laboratories (Allergan) Latest Developments
Table 104. Cobalt Laboratories (Allergan) Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 105. Auro Pharma Product Offered
Table 106. Auro Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 107. Auro Pharma Main Business
Table 108. Auro Pharma Latest Developments
Table 109. Auro Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 110. Remedy Repack Product Offered
Table 111. Remedy Repack Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 112. Remedy Repack Main Business
Table 113. Remedy Repack Latest Developments
Table 114. Remedy Repack Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 115. Biomed Pharma Product Offered
Table 116. Biomed Pharma Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 117. Biomed Pharma Main Business
Table 118. Biomed Pharma Latest Developments
Table 119. Biomed Pharma Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 120. Apotex Corporation Product Offered
Table 121. Apotex Corporation Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 122. Apotex Corporation Main Business
Table 123. Apotex Corporation Latest Developments
Table 124. Apotex Corporation Basic Information, Company Total Revenue (in $ million), Valacyclovir Manufacturing Base, Sales Area and Its Competitors
Table 125. Sichuan Mingxin Pharmaceutical Product Offered
Table 126. Sichuan Mingxin Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 127. Sichuan Mingxin Pharmaceutical Main Business
Table 128. Sichuan Mingxin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Sichuan Mingxin Pharmaceutical Latest Developments
Table 130. Sichuan Kelun Pharmaceutical Product Offered
Table 131. Sichuan Kelun Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 132. Sichuan Kelun Pharmaceutical Main Business
Table 133. Sichuan Kelun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Sichuan Kelun Pharmaceutical Latest Developments
Table 135. Sichuan Baili Pharmaceutical Product Offered
Table 136. Sichuan Baili Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 137. Sichuan Baili Pharmaceutical Main Business
Table 138. Sichuan Baili Pharmaceutical Latest Developments
Table 139. Sichuan Baili Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Marcan Pharmaceuticals Product Offered
Table 141. Marcan Pharmaceuticals Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 142. Marcan Pharmaceuticals Main Business
Table 143. Marcan Pharmaceuticals Latest Developments
Table 144. Marcan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Livzon Pharmaceutical Group Product Offered
Table 146. Livzon Pharmaceutical Group Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 147. Livzon Pharmaceutical Group Main Business
Table 148. Livzon Pharmaceutical Group Latest Developments
Table 149. Livzon Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Product Offered
Table 151. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 152. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Main Business
Table 153. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Latest Developments
Table 154. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Yichang Dongyangguang Changjiang Pharmaceutical Product Offered
Table 156. Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 157. Yichang Dongyangguang Changjiang Pharmaceutical Main Business
Table 158. Yichang Dongyangguang Changjiang Pharmaceutical Latest Developments
Table 159. Yichang Dongyangguang Changjiang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. Beijing Shuanglu Pharmaceutical Product Offered
Table 161. Beijing Shuanglu Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 162. Beijing Shuanglu Pharmaceutical Main Business
Table 163. Beijing Shuanglu Pharmaceutical Latest Developments
Table 164. Beijing Shuanglu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 165. Jamp Pharma Corporatio Product Offered
Table 166. Jamp Pharma Corporatio Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 167. Jamp Pharma Corporatio Main Business
Table 168. Jamp Pharma Corporatio Latest Developments
Table 169. Jamp Pharma Corporatio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 170. Ansi Pharmaceutical Product Offered
Table 171. Ansi Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 172. Ansi Pharmaceutical Main Business
Table 173. Ansi Pharmaceutical Latest Developments
Table 174. Ansi Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 175. Hubei Yikang Pharmaceutical Factory Product Offered
Table 176. Hubei Yikang Pharmaceutical Factory Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 177. Hubei Yikang Pharmaceutical Factory Main Business
Table 178. Hubei Yikang Pharmaceutical Factory Latest Developments
Table 179. Hubei Yikang Pharmaceutical Factory Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 180. Hubei Keyi Pharmaceutical Product Offered
Table 181. Hubei Keyi Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 182. Hubei Keyi Pharmaceutical Main Business
Table 183. Hubei Keyi Pharmaceutical Latest Developments
Table 184. Hubei Keyi Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 185. Yongxin Pharmaceutical Industry Product Offered
Table 186. Yongxin Pharmaceutical Industry Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 187. Yongxin Pharmaceutical Industry Main Business
Table 188. Yongxin Pharmaceutical Industry Latest Developments
Table 189. Yongxin Pharmaceutical Industry Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 190. Kunming Yuanrui Pharmaceutical Product Offered
Table 191. Kunming Yuanrui Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 192. Kunming Yuanrui Pharmaceutical Main Business
Table 193. Kunming Yuanrui Pharmaceutical Latest Developments
Table 194. Kunming Yuanrui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 195. Hubei Huashitong Qianlong Pharmaceutical Product Offered
Table 196. Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 197. Hubei Huashitong Qianlong Pharmaceutical Main Business
Table 198. Hubei Huashitong Qianlong Pharmaceutical Latest Developments
Table 199. Hubei Huashitong Qianlong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 200. Shandong Luoxin Pharmaceutical Group Product Offered
Table 201. Shandong Luoxin Pharmaceutical Group Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 202. Shandong Luoxin Pharmaceutical Group Main Business
Table 203. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 204. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 205. Zhuhai Rundu Pharmaceutical Product Offered
Table 206. Zhuhai Rundu Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 207. Zhuhai Rundu Pharmaceutical Main Business
Table 208. Zhuhai Rundu Pharmaceutical Latest Developments
Table 209. Zhuhai Rundu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 210. Guangdong Baike Pharmaceutical Product Offered
Table 211. Guangdong Baike Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 212. Guangdong Baike Pharmaceutical Main Business
Table 213. Guangdong Baike Pharmaceutical Latest Developments
Table 214. Guangdong Baike Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 215. Shandong New Era Pharmaceutical Product Offered
Table 216. Shandong New Era Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 217. Shandong New Era Pharmaceutical Main Business
Table 218. Shandong New Era Pharmaceutical Latest Developments
Table 219. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 220. Chengdu Beite Pharmaceutical Product Offered
Table 221. Chengdu Beite Pharmaceutical Valacyclovir Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 222. Chengdu Beite Pharmaceutical Main Business
Table 223. Chengdu Beite Pharmaceutical Latest Developments
Table 224. Chengdu Beite Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 225. Jamp Pharma Corporatio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 226. Marcan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Valacyclovir
Figure 2. Valacyclovir Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Valacyclovir Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Valacyclovir Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablets
Figure 7. Product Picture of Capsule
Figure 8. Product Picture of Granules
Figure 9. Global Valacyclovir Consumption Market Share by Type (2015-2020)
Figure 10. Global Valacyclovir Value Market Share by Type (2015-2020)
Figure 11. Valacyclovir Consumed in Herpes Zoster Virus
Figure 12. Global Valacyclovir Market: Herpes Zoster Virus (2015-2020) (KG)
Figure 13. Global Valacyclovir Market: Herpes Zoster Virus (2015-2020) ($ Millions)
Figure 14. Valacyclovir Consumed in Herpes Simplex Virus
Figure 15. Global Valacyclovir Market: Herpes Simplex Virus (2015-2020) (KG)
Figure 16. Global Valacyclovir Market: Herpes Simplex Virus (2015-2020) ($ Millions)
Figure 17. Valacyclovir Consumed in EB Virus
Figure 18. Global Valacyclovir Market: EB Virus (2015-2020) (KG)
Figure 19. Global Valacyclovir Market: EB Virus (2015-2020) ($ Millions)
Figure 20. Valacyclovir Consumed in Cytomegalovirus
Figure 21. Global Valacyclovir Market: Cytomegalovirus (2015-2020) (KG)
Figure 22. Global Valacyclovir Market: Cytomegalovirus (2015-2020) ($ Millions)
Figure 23. Global Valacyclovir Consumption Market Share by Application (2015-2020)
Figure 24. Global Valacyclovir Value Market Share by Application (2015-2020)
Figure 25. Global Valacyclovir Sales Market Share by Company in 2017
Figure 26. Global Valacyclovir Sales Market Share by Company in 2019
Figure 27. Global Valacyclovir Revenue Market Share by Company in 2017
Figure 28. Global Valacyclovir Revenue Market Share by Company in 2019
Figure 29. Global Valacyclovir Sale Price by Company in 2019
Figure 30. Global Valacyclovir Consumption Market Share by Regions 2015-2020
Figure 31. Global Valacyclovir Value Market Share by Regions 2015-2020
Figure 32. Americas Valacyclovir Consumption 2015-2020 (KG)
Figure 33. Americas Valacyclovir Value 2015-2020 ($ Millions)
Figure 34. APAC Valacyclovir Consumption 2015-2020 (KG)
Figure 35. APAC Valacyclovir Value 2015-2020 ($ Millions)
Figure 36. Europe Valacyclovir Consumption 2015-2020 (KG)
Figure 37. Europe Valacyclovir Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Valacyclovir Consumption 2015-2020 (KG)
Figure 39. Middle East & Africa Valacyclovir Value 2015-2020 ($ Millions)
Figure 40. Americas Valacyclovir Consumption Market Share by Countries in 2019
Figure 41. Americas Valacyclovir Value Market Share by Countries in 2019
Figure 42. Americas Valacyclovir Consumption Market Share by Type in 2019
Figure 43. Americas Valacyclovir Consumption Market Share by Application in 2019
Figure 44. United States Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 45. United States Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 47. Canada Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 49. Mexico Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Valacyclovir Consumption Market Share by Countries in 2019
Figure 51. APAC Valacyclovir Value Market Share by Regions in 2019
Figure 52. APAC Valacyclovir Consumption Market Share by Type in 2019
Figure 53. APAC Valacyclovir Consumption Market Share by Application in 2019
Figure 54. China Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 55. China Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 57. Japan Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 59. Korea Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 61. Southeast Asia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 62. India Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 63. India Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 65. Australia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Valacyclovir Consumption Market Share by Countries in 2019
Figure 67. Europe Valacyclovir Value Market Share by Countries in 2019
Figure 68. Europe Valacyclovir Consumption Market Share by Type in 2019
Figure 69. Europe Valacyclovir Consumption Market Share by Application in 2019
Figure 70. Germany Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 71. Germany Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 72. France Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 73. France Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 74. UK Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 75. UK Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 77. Italy Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 79. Russia Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Valacyclovir Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Valacyclovir Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Valacyclovir Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Valacyclovir Consumption Market Share by Application in 2019
Figure 84. Egypt Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 85. Egypt Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 87. South Africa Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 89. Israel Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 91. Turkey Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Valacyclovir Consumption Growth 2015-2020 (KG)
Figure 93. GCC Countries Valacyclovir Value Growth 2015-2020 ($ Millions)
Figure 94. Global Valacyclovir Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 95. Global Valacyclovir Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Valacyclovir Consumption 2021-2025 (KG)
Figure 97. Americas Valacyclovir Value 2021-2025 ($ Millions)
Figure 98. APAC Valacyclovir Consumption 2021-2025 (KG)
Figure 99. APAC Valacyclovir Value 2021-2025 ($ Millions)
Figure 100. Europe Valacyclovir Consumption 2021-2025 (KG)
Figure 101. Europe Valacyclovir Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Valacyclovir Consumption 2021-2025 (KG)
Figure 103. Middle East & Africa Valacyclovir Value 2021-2025 ($ Millions)
Figure 104. United States Valacyclovir Consumption 2021-2025 (KG)
Figure 105. United States Valacyclovir Value 2021-2025 ($ Millions)
Figure 106. Canada Valacyclovir Consumption 2021-2025 (KG)
Figure 107. Canada Valacyclovir Value 2021-2025 ($ Millions)
Figure 108. Mexico Valacyclovir Consumption 2021-2025 (KG)
Figure 109. Mexico Valacyclovir Value 2021-2025 ($ Millions)
Figure 110. Brazil Valacyclovir Consumption 2021-2025 (KG)
Figure 111. Brazil Valacyclovir Value 2021-2025 ($ Millions)
Figure 112. China Valacyclovir Consumption 2021-2025 (KG)
Figure 113. China Valacyclovir Value 2021-2025 ($ Millions)
Figure 114. Japan Valacyclovir Consumption 2021-2025 (KG)
Figure 115. Japan Valacyclovir Value 2021-2025 ($ Millions)
Figure 116. Korea Valacyclovir Consumption 2021-2025 (KG)
Figure 117. Korea Valacyclovir Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Valacyclovir Consumption 2021-2025 (KG)
Figure 119. Southeast Asia Valacyclovir Value 2021-2025 ($ Millions)
Figure 120. India Valacyclovir Consumption 2021-2025 (KG)
Figure 121. India Valacyclovir Value 2021-2025 ($ Millions)
Figure 122. Australia Valacyclovir Consumption 2021-2025 (KG)
Figure 123. Australia Valacyclovir Value 2021-2025 ($ Millions)
Figure 124. Germany Valacyclovir Consumption 2021-2025 (KG)
Figure 125. Germany Valacyclovir Value 2021-2025 ($ Millions)
Figure 126. France Valacyclovir Consumption 2021-2025 (KG)
Figure 127. France Valacyclovir Value 2021-2025 ($ Millions)
Figure 128. UK Valacyclovir Consumption 2021-2025 (KG)
Figure 129. UK Valacyclovir Value 2021-2025 ($ Millions)
Figure 130. Italy Valacyclovir Consumption 2021-2025 (KG)
Figure 131. Italy Valacyclovir Value 2021-2025 ($ Millions)
Figure 132. Russia Valacyclovir Consumption 2021-2025 (KG)
Figure 133. Russia Valacyclovir Value 2021-2025 ($ Millions)
Figure 134. Spain Valacyclovir Consumption 2021-2025 (KG)
Figure 135. Spain Valacyclovir Value 2021-2025 ($ Millions)
Figure 136. Egypt Valacyclovir Consumption 2021-2025 (KG)
Figure 137. Egypt Valacyclovir Value 2021-2025 ($ Millions)
Figure 138. South Africa Valacyclovir Consumption 2021-2025 (KG)
Figure 139. South Africa Valacyclovir Value 2021-2025 ($ Millions)
Figure 140. Israel Valacyclovir Consumption 2021-2025 (KG)
Figure 141. Israel Valacyclovir Value 2021-2025 ($ Millions)
Figure 142. Turkey Valacyclovir Consumption 2021-2025 (KG)
Figure 143. Turkey Valacyclovir Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Valacyclovir Consumption 2021-2025 (KG)
Figure 145. GCC Countries Valacyclovir Value 2021-2025 ($ Millions)
Figure 146. GSK Valacyclovir Market Share (2018-2020)
Figure 147. PLIVA Valacyclovir Market Share (2018-2020)
Figure 148. Mylan Pharmaceuticals Valacyclovir Market Share (2018-2020)
Figure 149. Sorres Pharma Valacyclovir Market Share (2018-2020)
Figure 150. Sivem Pharmaceuticals Valacyclovir Market Share (2018-2020)
Figure 151. Cobalt Laboratories (Allergan) Valacyclovir Market Share (2018-2020)
Figure 152. Auro Pharma Valacyclovir Market Share (2018-2020)
Figure 153. Remedy Repack Valacyclovir Market Share (2018-2020)
Figure 154. Biomed Pharma Valacyclovir Market Share (2018-2020)
Figure 155. Apotex Corporation Valacyclovir Market Share (2018-2020)
Figure 156. Sichuan Mingxin Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 157. Sichuan Kelun Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 158. Sichuan Baili Pharmaceutical Valacyclovir Market Share (2018-2020)
Figure 159. Marc
